Crosstalk between circRNAs and the classic signaling pathways in IBD.
Researchers are exploring circRNAs as new molecular players in IBD inflammation; that could lead to future biomarker tests or novel treatments targeting immune pathways relevant to Crohn’s disease and ulcerative colitis.
For patients, this is early-stage research that may influence diagnostics or therapies down the line but does not change current care now.
Researchers studying IBD molecular mechanisms, clinicians interested in biomarkers and translational research, and patients following emerging diagnostic or therapeutic research.
What To Know
This review article summarizes current knowledge about circular RNAs (circRNAs) in IBD and how they interact with classic inflammatory signaling pathways (for example JAK/STAT and NF-κB). It highlights that many circRNAs show disease-specific expression and are being investigated as potential diagnostic or prognostic biomarkers and therapeutic targets.
The source material provided is an abstract-level summary from the journal RNA Biology; the full review was not supplied here. The paper is a review, not a clinical trial.
It synthesizes lab and early translational research linking circRNAs to immune signaling pathways implicated in IBD pathogenesis, and discusses challenges for moving circRNA findings toward clinical use. It does not provide clinical recommendations or validated diagnostic tests.
If you follow IBD research: this points to emerging molecular biomarkers and possible future therapies that target RNA-mediated pathways, but these ideas are still at an early research stage. Keep reading the full article or subsequent clinical studies to see whether specific circRNA markers or interventions progress to clinical validation.
This is an abstract/summary of a review article (RNA Biology). The content reflects preclinical and early translational literature; it does not report clinical validation of circRNA biomarkers or approved therapies. Interpret findings as exploratory until validated in clinical studies.